Evidence map›Paper›PMID 34185881›Full record

ArticleCancer2021

Sociodemographic and hospital-based predictors of intense end-of-life care among children, adolescents, and young adults with hematologic malignancies.

Sophia Mun, Rong Wang, Xiaomei Ma, Prasanna Ananth

Open access · greenAbstract read
In one paragraph

Article in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pediatric Oncology Hospice: A Comprehensive Review.The American journal of hospice & palliative care · 2024
    Review
  3. Observational
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sophia MunYale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, Connecticut.ORCID 0000-0002-9972-9824
Rong WangYale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, Connecticut.ORCID 0000-0002-2169-4174
Xiaomei MaYale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, Connecticut.
Prasanna AnanthYale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, Connecticut.ORCID 0000-0002-5614-7445
Yale Cancer Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The Pediatric Advanced Cancer Experience (PACE): Measuring Quality of End-of-Life Care for Children with CancerK08CA259222 · NCI · YALE UNIVERSITY · PI ANANTH, PRASANNA J · 2021 to 2025
$1.1M
NCATS NIH HHS UL1 TR001863NCI NIH HHS K08 CA259222NCI NIH HHS L40 CA231699
6 · The paper itself

Abstract

backgroundChildren, adolescents, and young adults with hematologic malignancies tend to receive high-intensity end-of-life care (HI-EOLC), but sociodemographic and hospital-based predictors of HI-EOLC remain unclear.

methodsThe authors conducted a population-based, retrospective cohort study with the Premier Healthcare Database. They identified individuals with hematologic malignancies who were 0 to 39 years old at death and died between 2010 and 2017. HI-EOLC was defined as experiencing 2 or more of the following: cardiopulmonary resuscitation, intravenous chemotherapy, hemodialysis, mechanical ventilation, tracheostomy placement, or an emergency department visit within the last 30 days of life and death in the intensive care unit. Multivariable logistic regression models were constructed to identify patient sociodemographic and hospital characteristics associated with HI-EOLC.

resultsAmong 1454 decedents, more than half (55%) experienced HI-EOLC. In multivariable models, patients treated in medium (adjusted odds ratio [aOR], 1.63; 95% confidence interval [CI], 1.07-2.50) or large hospitals (aOR, 2.21; 95% CI, 1.45-3.39), insured by Medicaid (aOR, 1.40 ; 95% CI, 1.09-2.06), or receiving cancer-directed treatment in the Northeast (aOR, 1.50; 95% CI, 1.05-2.15) were more likely to receive HI-EOLC.

conclusionsA majority of children, adolescents, and young adults with hematologic malignancies experienced HI-EOLC, and the likelihood of HI-EOLC was influenced by the hospital size, type of insurance, and geographic region. Further research is needed to determine how to mitigate these risks.

Indexed as

Hematologic NeoplasmsHospice CareTerminal CareAdolescentAdultChildChild, PreschoolHospitalsHumansInfantInfant, NewbornPalliative CareRetrospective StudiesYoung Adultend-of-life carehematologic malignanciespediatricpediatric oncologypediatric palliative care

Identifiers

PMID34185881
PMCPMC8478813
OpenAlexW3177192372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.